Advertisement
Home Tags Diabetes: Type II

Tag: Diabetes: Type II

For patients with type 2 diabetes

Follow-Up Phone Calls May Boost Glycemic Control in T2DM

No statistically significant change in hemoglobin A1c, but clinically significant change observed
Metformin seems to alter gut microbiota composition

Metformin Alters Gut Microbiota Composition in Diabetes

Higher relative abundance of A. muciniphila, SCFA-producing microbiota for metformin-treated diabetes
For African-Americans with type 2 diabetes

DECIDE Modalities Beneficial for African-Americans With T2DM

Most robust improvements seen for Self-Study modality, including HbA1c, blood pressure, lipids
The risk of cardiovascular outcomes is elevated for women with gestational diabetes mellitus

Women With GDM Have Elevated Risk of Future Cardiac Events

Increased risk of cardiovascular outcomes, even in the absence of type 2 diabetes mellitus
Reduced baseline levels of circulating CD34+ stem cells predict adverse cardiovascular outcomes for patients with type 2 diabetes

Reduced CD34+ Stem Cells Predicts CV Outcome in T2DM

Long-term prediction of cardiovascular outcomes by circulating CD34+ and CD34+CD133+ cells
For patients with type 2 diabetes receiving inpatient diabetes education

With Education, Discharge Blood Glucose Profile Predicts HbA1c

Mean blood glucose level, disease duration predict 12-week HbA1c level after inpatient education
High ceramide levels may increase diabetes risk

Blocking Ceramide Production Might Prevent Type 2 Diabetes

Ceramides may impact way the body handles nutrients and responds to insulin
For patients without diabetes

Incidence of Statin-Associated T2DM Relatively Low

Diabetogenic impact of statins increases as fasting plasma glucose, triglycerides, and BMI increase
For elderly adults

Reduction of Chemical Exposure Cuts Diabetes in Elderly

Twenty-five percent reduction in chemical exposure could prevent 152,481 cases of diabetes in Europe
Diabetes-related distress and depression symptom severity are risk factors for medication nonadherence in type 2 diabetes

Diabetes-Related Distress Ups Risk for Rx Nonadherence

Depression is independent predictor of adherence; reduces the effects of diabetes distress